Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study

Authors
Category Primary study
JournalCurrent Therapeutic Research - Clinical and Experimental
Year 2018
This article has no abstract
Epistemonikos ID: 47f5eb74def5cbd6a254da0ff2f12ad0eca9113d
First added on: Feb 09, 2025